Your browser doesn't support javascript.
loading
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter.
Lim, Michael; Weller, Michael; Idbaih, Ahmed; Steinbach, Joachim; Finocchiaro, Gaetano; Raval, Raju R; Ansstas, George; Baehring, Joachim; Taylor, Jennie W; Honnorat, Jerome; Petrecca, Kevin; De Vos, Filip; Wick, Antje; Sumrall, Ashley; Sahebjam, Solmaz; Mellinghoff, Ingo K; Kinoshita, Masashi; Roberts, Mustimbo; Slepetis, Ruta; Warad, Deepti; Leung, David; Lee, Michelle; Reardon, David A; Omuro, Antonio.
Afiliação
  • Lim M; Department of Neurosurgery, Stanford University School of Medicine, Palo Alto, California, USA.
  • Weller M; Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland.
  • Idbaih A; Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, AP-HP, Hôpital Universitaire La Pitié Salpêtrière, Paris, France.
  • Steinbach J; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.
  • Finocchiaro G; Institute of Neurooncology, Goethe University Hospital, Frankfurt, Germany.
  • Raval RR; Unit of Molecular Neuro-Oncology, Neurological Institute C. Besta, Milan, Italy.
  • Ansstas G; Translational Therapeutics Program, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
  • Baehring J; Department of Medicine, Oncology Division, Washington University Medical School, St. Louis, Missouri, USA.
  • Taylor JW; Department of Neurology, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Honnorat J; Departments of Neurology and Neurological Surgery, University of California San Francisco, San Francisco, California, USA.
  • Petrecca K; Neuro-Oncology Department, Hospices Civils de Lyon, SynatAc Team, Institute MeLis, INSERM U1314/CNRS UMR 5284, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
  • De Vos F; Department of Neurology and Neurosurgery, Brain Tumour Research Centre, Montreal Neurological Institute-Hospital, McGill University, Montreal, Quebec, Canada.
  • Wick A; Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Sumrall A; Neurology Clinic, University of Heidelberg, National Center for Tumor Diseases, Heidelberg, Germany.
  • Sahebjam S; Neuro-Oncology Department, Levine Cancer Institute, Charlotte, North Carolina, USA.
  • Mellinghoff IK; Moffitt Cancer Center, University of South Florida, Tampa, Florida, USA.
  • Kinoshita M; Department of Neurology and Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Roberts M; Department of Neurosurgery, Kanazawa University, Ishikawa, Japan.
  • Slepetis R; Bristol Myers Squibb, Princeton, New Jersey, USA.
  • Warad D; Bristol Myers Squibb, Princeton, New Jersey, USA.
  • Leung D; Bristol Myers Squibb, Princeton, New Jersey, USA.
  • Lee M; Bristol Myers Squibb, Princeton, New Jersey, USA.
  • Reardon DA; Syneos Health, Morrisville, North Carolina, USA.
  • Omuro A; Center for Neuro-Oncology, Dana-Farber/Harvard Cancer Center, Boston, Massachusetts, USA.
Neuro Oncol ; 24(11): 1935-1949, 2022 11 02.
Article em En | MEDLINE | ID: mdl-35511454
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Revista: Neuro Oncol Assunto da revista: NEOPLASIAS / NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Revista: Neuro Oncol Assunto da revista: NEOPLASIAS / NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido